Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Cash from Operations (2016 - 2026)

Catalyst Pharmaceuticals filings provide 17 years of Cash from Operations readings, the most recent being 59587000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 0.76% to 59587000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 208214000.0, a 22.29% decrease, with the full-year FY2025 number at 208670000.0, down 12.98% from a year prior.
  • Cash from Operations hit 59587000.0 in Q1 2026 for Catalyst Pharmaceuticals, up from 44891000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 72871000.0 in Q3 2024 to a low of 8478000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 44891000.0 (2025), compared with a mean of 45159529.41.
  • Biggest five-year swings in Cash from Operations: surged 164.5% in 2024 and later tumbled 55.49% in 2025.
  • Catalyst Pharmaceuticals' Cash from Operations stood at 40077000.0 in 2022, then skyrocketed by 38.85% to 55648000.0 in 2023, then increased by 27.37% to 70877000.0 in 2024, then plummeted by 36.66% to 44891000.0 in 2025, then soared by 32.74% to 59587000.0 in 2026.
  • The last three reported values for Cash from Operations were 59587000.0 (Q1 2026), 44891000.0 (Q4 2025), and 32438000.0 (Q3 2025) per Business Quant data.